Tannerella forsythia-produced methylglyoxal causes accumulation of advanced glycation endproducts to trigger cytokine secretion in human monocytes

The periodontal pathogen Tannerella forsythia has the unique ability to produce methylglyoxal (MGO), an electrophilic compound which can covalently modify amino acid side chains and generate inflammatory adducts known as advanced glycation endproducts (AGEs). In periodontitis, concentrations of MGO...

Full description

Bibliographic Details
Main Authors: Browne, R.W (Author), Genco, R.J (Author), Honma, K. (Author), LaMonte, M. (Author), Li, M. (Author), Settem, R.P (Author), Shankar, M. (Author), Sharma, A. (Author), Xu, D. (Author)
Format: Article
Language:English
Published: Blackwell Publishing Ltd 2018
Subjects:
Online Access:View Fulltext in Publisher
LEADER 04230nam a2200925Ia 4500
001 10.1111-omi.12224
008 220706s2018 CNT 000 0 und d
020 |a 20411006 (ISSN) 
245 1 0 |a Tannerella forsythia-produced methylglyoxal causes accumulation of advanced glycation endproducts to trigger cytokine secretion in human monocytes 
260 0 |b Blackwell Publishing Ltd  |c 2018 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1111/omi.12224 
520 3 |a The periodontal pathogen Tannerella forsythia has the unique ability to produce methylglyoxal (MGO), an electrophilic compound which can covalently modify amino acid side chains and generate inflammatory adducts known as advanced glycation endproducts (AGEs). In periodontitis, concentrations of MGO in gingival-crevicular fluid are increased and are correlated with the T. forsythia load. However, the source of MGO and the extent to which MGO may contribute to periodontal inflammation has not been fully explored. In this study we identified a functional homolog of the enzyme methylglyoxal synthase (MgsA) involved in the production of MGO in T. forsythia. While wild-type T.forsythia produced a significant amount of MGO in the medium, a mutant lacking this homolog produced little to no MGO. Furthermore, compared with the spent medium of the T. forsythia parental strain, the spent medium of the T. forsythia mgsA-deletion strain induced significantly lower nuclear factor-kappa B activity as well as proinflammogenic and pro-osteoclastogenic cytokines from THP-1 monocytes. The ability of T. forsythia to induce protein glycation endproducts via MGO was confirmed by an electrophoresis-based collagen chain mobility shift assay. Together these data demonstrated that T. forsythia produces MGO, which may contribute to inflammation via the generation of AGEs and thus act as a potential virulence factor of the bacterium. © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 
650 0 4 |a advanced glycation end product 
650 0 4 |a advanced glycation end product receptor 
650 0 4 |a AGEs 
650 0 4 |a Article 
650 0 4 |a bacterial enzyme 
650 0 4 |a bacterial load 
650 0 4 |a bacterial strain 
650 0 4 |a bacterial virulence 
650 0 4 |a controlled study 
650 0 4 |a cytokine 
650 0 4 |a cytokine release 
650 0 4 |a Cytokines 
650 0 4 |a deletion mutant 
650 0 4 |a gel mobility shift assay 
650 0 4 |a Glycation End Products, Advanced 
650 0 4 |a high mobility group B1 protein 
650 0 4 |a human 
650 0 4 |a human cell 
650 0 4 |a Humans 
650 0 4 |a immunogenicity 
650 0 4 |a immunoglobulin enhancer binding protein 
650 0 4 |a inflammation 
650 0 4 |a Inflammation 
650 0 4 |a interleukin 10 
650 0 4 |a interleukin 1beta 
650 0 4 |a interleukin 6 
650 0 4 |a MAPK signaling 
650 0 4 |a metabolism 
650 0 4 |a methylglyoxal 
650 0 4 |a methylglyoxal synthase 
650 0 4 |a microbiology 
650 0 4 |a mitogen activated protein kinase p38 
650 0 4 |a monocyte 
650 0 4 |a Monocytes 
650 0 4 |a mutant 
650 0 4 |a nonhuman 
650 0 4 |a osteoclastogenesis 
650 0 4 |a pathogenicity 
650 0 4 |a periodontitis 
650 0 4 |a Periodontitis 
650 0 4 |a phosphatase 
650 0 4 |a protein degradation 
650 0 4 |a protein function 
650 0 4 |a protein glycosylation 
650 0 4 |a Pyruvaldehyde 
650 0 4 |a RAGE 
650 0 4 |a secreted embryonic alkaline phosphatase 
650 0 4 |a stress activated protein kinase 
650 0 4 |a synthetase 
650 0 4 |a Tannerella forsythia 
650 0 4 |a THP-1 cell line 
650 0 4 |a THP-1 Cells 
650 0 4 |a transcription factor AP 1 
650 0 4 |a tumor necrosis factor 
650 0 4 |a unclassified drug 
650 0 4 |a virulence factor 
650 0 4 |a Virulence Factors 
650 0 4 |a wild type 
700 1 |a Browne, R.W.  |e author 
700 1 |a Genco, R.J.  |e author 
700 1 |a Honma, K.  |e author 
700 1 |a LaMonte, M.  |e author 
700 1 |a Li, M.  |e author 
700 1 |a Settem, R.P.  |e author 
700 1 |a Shankar, M.  |e author 
700 1 |a Sharma, A.  |e author 
700 1 |a Xu, D.  |e author 
773 |t Molecular Oral Microbiology